SCHEMBL6602268

SCHEMBL6602268

CCOc1ccc(C(=O)Nc2ccc3c(c2Cl)CNCC3)cc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.49
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 2/20 0.49
LMNA P02545 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C19 P33261 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
POLB P06746 1/20 0.49
CYP2C9 P11712 1/20 0.49
HPGD P15428 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
NR4A1 P22736 1/20 0.47
TP53 P04637 5/20 0.46
NPC1 O15118 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604412 0.90 NPC1 (0.52) MAPTKDM4EALDH1A1LMNACYP3A4
SCHEMBL6602962 0.89 MAPT (0.55) MAPTKDM4EALDH1A1LMNACYP3A4
SCHEMBL6600619 0.88 CREBBP (0.46) MAPTKDM4EALDH1A1LMNACYP3A4
SCHEMBL5874018 0.88 MAPT (0.49) MAPTKDM4EALDH1A1HSD17B10LMNA
SCHEMBL8120517 0.83 NPC1 (0.46) MAPTKDM4EALDH1A1LMNACYP3A4
SCHEMBL6601797 0.82 MAPT (0.55) MAPTKDM4EALDH1A1HSD17B10LMNA
SCHEMBL5874134 0.81 MAPT (0.53) MAPTKDM4EALDH1A1HSD17B10LMNA
SCHEMBL6601808 0.81 CREBBP (0.47) MAPTHSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL8145894 0.80 MAPT (0.38) MAPTKDM4EALDH1A1HSD17B10LMNA
SCHEMBL6607827 0.80 MAPT (0.38) MAPTKDM4EALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
CN-1125052-C Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM PLC (GB) 2003-10-22 CN disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
CN-1284946-A Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM PLC (GB) 2001-02-21 CN disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed